XGN - Exagen Inc
Exagen Inc Logo

XGN - Exagen Inc

https://www.exagen.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Exagen Inc. develops and markets various test products based on its Cell-Bound Complement Activation Products technology under the AVISE brand name in the United States. The company is headquartered in Vista, California.

52W High
$10.34
52W Low
$2.38
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.61
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-0.16
EV/Revenue (<3 favorable)
3.53
P/S (TTM) (<3 favorable)
3.62
P/B (<3 favorable)
10.12
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
15.29%
Institutions (25–75% balanced)
57.81%
Shares Outstanding
22,003,600
Float
14,355,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
58,862,000
Gross Profit (TTM)
34,976,000
EPS (TTM)
-0.89
Profit Margin (>10% good)
-0.29%
Operating Margin (TTM) (higher better)
-0.15%
ROE (TTM) (>15% strong)
-0.88%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.14
Momentum
Bearish momentum
Value
0.2986
Previous
0.3263
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025